bioRxiv Science⌕ Search

Biology subjects

Dhakephalkar, T.

Publications and source records attributed to Dhakephalkar, T..

2 recordsLinked to original sources

Characterization of an evolutionarily distinct bacterial ceramide kinase from Caulobacter crescentus

A common feature among nearly all Gram-negative bacteria is the requirement for lipopolysaccharide (LPS) in the outer leaflet of the outer membrane. LPS provides structural integrity to the bacterial membrane which aids bacteria in maintaining their shape and acts as a barrier from environmental stress and harmful substances such as detergents and antibiotics. Recent work has demonstrated that Caulobacter crescentus can survive without LPS due to the presence of the anionic sphingolipid ceramide-phosphoglycerate. Based on genetic evidence, we predicted that protein CpgB functions as a ceramide kinase and performs the first step in generating the phosphoglycerate head group. Here, we characterized the kinase activity of recombinantly expressed CpgB and demonstrated that it can phosphorylate ceramide to form ceramide 1-phosphate. The pH optimum for CpgB was 7.5, and the enzyme required Mg2+ as a cofactor. Mn2+, but not other divalent cations, could substitute for Mg2+. Under these conditions, the enzyme exhibited typical Michaelis-Menten kinetics with respect to NBD-C6-ceramide (Km,app=19.2 {+/-} 5.5 M; Vmax,app=2586.29 {+/-} 231.99 pmol/min/mg enzyme) and ATP (Km,app=0.29 {+/-} 0.07 mM; Vmax,app=10067.57 {+/-} 996.85 pmol/min/mg enzyme). Phylogenetic analysis of CpgB revealed that CpgB belongs to a new class of ceramide kinases which is distinct from its eukaryotic counterpart; furthermore, the pharmacological inhibitor of human ceramide kinase (NVP-231) had no effect on CpgB. The characterization of a new bacterial ceramide kinase opens avenues for understanding the structure and function of the various microbial phosphorylated sphingolipids.

biochemistry↗

Genomic evaluation of BC4, a consortium of four Alkalihalobacillus clausii isolates, confirms its probiotic potential and safety in usage

Four strains of Alkalihalobacillus clausii B603/Nb (resistant to rifampicin), B619/R (resistant to streptomycin), B637/Nm (resistant to tetracyclin) and B106 (resistant to chloramphenicol) were isolated from various sources and used to prepare a consortium designated as BC4. Genomes of the constituent strains of the BC4 consortium were evaluated to investigate their genetic makeup and determine their probiotic potential. Gene prediction and functional annotation were performed using RAST. The data obtained was mined for genes encoding various phenotypic traits. This analysis revealed the presence of several genes encoding probiotic attributes like (i) survivability in the presence of low pH, bile, oxidative stress; (ii) bacterial aggregation and adhesion to gut epithelium, etc.; and (iii) enzymes/ molecules conferring health benefits. Further, the genome analysis also confirmed the genes required for enhancing the nutritional amenability, health-promoting, and disease-preventing traits were present. Several genes encoding multiple antibiotic resistance were detected; however, none of these genes was located on mobile elements such as plasmids, transposons, etc. The absence of genes encoding virulence factors, pathogenic islands, emetic toxins, etc., as well as mobile genetic elements, underscored the safety of BC4 isolates.

microbiology↗